Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. METHODS: We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6). RESULTS: There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). CONCLUSIONS: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended (Fig. 10.5), in part because these high-risk people should already be receiving intensive medical therapy-an approach that provides benefits similar to those of invasive revascularization (208,209).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [208]
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended, in part because these high-risk people should already be receiving intensive medical therapy—an approach that provides benefits similar to those of invasive revascularization (197,198).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [197]
In the citing paper
“OMT with risk modification remains the foundation of management in patients with T2DM and CAD.263,264”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [264]
In the citing paper
“these high-risk patients should already be receiving intensive medical therapy -an approach that provides benefi t similar to invasive revascularization (172,173).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [172]
In the citing paper
“The screening of asymptomatic patients remains controversial, especially as intensive medical therapy indicated in diabetic patients at high risk for CVD has an increasing evidence base for providing equal outcomes to invasive revascularization, including in diabetic patients (222).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [222]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Research works printed but not linked: 2
- 1994, Lancet, 344, 1383
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
Cited by
Items 101–200 of 1,002
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Das, S. R., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s010 · Cited by 465
Hachamovitch, R., Rozanski, A., Shaw, L. J., Stone, G. W., Thomson, L. E. J., Friedman, J. D., Hayes, S. W., Cohen, I., Germano, G., & Berman, D. S. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq500 · Cited by 481
Self-citationPerioperative Myocardial Infarction
Landesberg, G., Beattie, W. S., Mosseri, M., Jaffe, A. S., & Alpert, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.828228 · Cited by 474
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease
Spertus, J. A., Jones, P. G., Maron, D. J., O’Brien, S. M., Reynolds, H. R., Rosenberg, Y., Stone, G. W., Harrell, F. E., Boden, W. E., Weintraub, W. S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916370 · Cited by 468
Self-citation10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s010 · Cited by 471
Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer
Li, D. (2009) · JAMA · doi:10.1001/jama.2009.886 · Cited by 469
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
Beckman, J. A., Paneni, F., Cosentino, F., & Creager, M. A. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht142 · Cited by 434
“comes of optimal medical therapy (OMT) with and without percutaneous coronary intervention (PCI).(152) Over a median 4.”
Method10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Das, S. R., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s010 · Cited by 438
Gulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E., Bhatt, D. L., Birtcher, K. K., Blankstein, R., Boyd, J., Bullock-Palmer, R. P., Conejo, T., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001030 · Cited by 428
Self-citationICRP Publication 120: Radiological Protection in Cardiology
Cousins, C., Miller, D. L., Bernardi, G., Rehani, M. M., Schofield, P., Vañó, E., Einstein, A. J., Geiger, B., Heintz, P., Padovani, R., et al. (2013) · Annals of the ICRP · doi:10.1016/j.icrp.2012.09.001 · Cited by 428
“A number of factors are probably responsible, including increased use of cardiac CT, the results of the COURAGE trial (Boden et al., 2007), and changes in reimbursement for these procedures.”
BackgroundGoel, K., Lennon, R. J., Tilbury, R. T., Squires, R. W., & Thomas, R. J. (2011) · Circulation · doi:10.1161/circulationaha.110.983536 · Cited by 423
“Elective 418 (29) 196 (20) 169 (24) 169 (24)”
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0224 · Cited by 418
PCI or CABG in coronary artery disease?
Taggart, D. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60574-2 · Cited by 416
Gardner, C. M., Tan, H., Hull, E. L., Lisauskas, J. B., Sum, S. T., Meese, T. M., Jiang, C., Madden, S. P., Caplan, J. D., Burke, A. P., et al. (2008) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.06.001 · Cited by 413
Technology Growth and Expenditure Growth in Health Care
Chandra, A., & Skinner, J. (2012) · Journal of Economic Literature · doi:10.1257/jel.50.3.645 · Cited by 412
Bittencourt, M. S., Hulten, E., Ghoshhajra, B., O’Leary, D., Christman, M. P., Montana, P., Truong, Q. A., Steigner, M., Murthy, V. L., Rybicki, F. J., et al. (2014) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.113.001047 · Cited by 403
Effectiveness of recanalization of chronic total occlusions: A systematic review and meta-analysis
Joyal, D., Afilalo, J., & Rinfret, S. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.04.015 · Cited by 402
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
Lentine, K. L., Costa, S. P., Weir, M. R., Robb, J. F., Fleisher, L. A., Kasiske, B. L., Carithers, R. L., Ragosta, M., Bolton, K., Auerbach, A. D., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.008 · Cited by 399
Garcia, S., Sandoval, Y., Roukoz, H., Adabag, S., Canoniero, M., Yannopoulos, D., & Brilakis, E. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.033 · Cited by 393
“Finally, the role of contemporary medical therapy in patients with residual CAD, although not the focus of our study, should not be underestimated (34).”
BackgroundQaseem, A., Fihn, S. D., Williams, S., Dallas, P., Owens, D. K., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00010 · Cited by 393
CT or Invasive Coronary Angiography in Stable Chest Pain
The DISCHARGE Trial Group (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200963 · Cited by 363
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., de las Fuentes, L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001285 · Cited by 365
A Decade of Reversal: An Analysis of 146 Contradicted Medical Practices
Prasad, V., Vandross, A., Toomey, C., Cheung, M., Rho, J., Quinn, S., Chacko, S. J., Borkar, D., Gall, V., Selvaraj, S., et al. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.05.012 · Cited by 381
“Stenting for stable coronary artery disease was a multibillion dollar a year industry when it was found to be no better than medical management for most patients with stable coronary artery disease.(1) Hormone therapy for postmenopausal women intended to improve cardiovascular outcomes was found to be worse than no in…”
BackgroundGénéreux, P., Palmerini, T., Caixeta, A., Rosner, G., Green, P., Dressler, O., Xu, K., Parise, H., Mehran, R., Serruys, P. W., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.010 · Cited by 374
Appropriateness of Percutaneous Coronary Intervention
Chan, P. S., Patel, M. R., Klein, L. W., Krone, R. J., Dehmer, G. J., Kennedy, K., Nallamothu, B. K., Weaver, W. D., Masoudi, F. A., Rumsfeld, J. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.916 · Cited by 367
Self-citation2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.005 · Cited by 367
Self-citationRecanalisation of Chronic Total coronary Occlusions: 2012 consensus document from the EuroCTO club
Sianos, G., Werner, G. S., Galassi, A. R., Papafaklis, M. I., Escaned, J., Hildick-Smith, D., Christiansen, E. H., Gershlick, A., Carlino, M., Karlas, A., et al. (2012) · EuroIntervention · doi:10.4244/eijv8i1a21 · Cited by 366
Cardiovascular Disease Risk Factors: Epidemiology and Risk Assessment
Dahlöf, B. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.007 · Cited by 359
Windecker, S., Stortecky, S., Stefanini, G. G., daCosta, B. R., Rutjes, A. W., Di Nisio, M., Siletta, M. G., Maione, A., Alfonso, F., Clemmensen, P. M., et al. (2014) · BMJ · doi:10.1136/bmj.g3859 · Cited by 356
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318212bb8b · Cited by 343
Kaski, J.-C., Crea, F., Gersh, B. J., & Camici, P. G. (2018) · Circulation · doi:10.1161/circulationaha.118.031373 · Cited by 340
Tardif, J.-C., Ponikowski, P., Kahan, T., & for the ASSOCIATE study Investigators (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn571 · Cited by 340
Muhlestein, J. B., Lappé, D. L., Lima, J. A. C., Rosen, B. D., May, H. T., Knight, S., Bluemke, D. A., Towner, S. R., Le, V., Bair, T. L., et al. (2014) · JAMA · doi:10.1001/jama.2014.15825 · Cited by 373
Chronic Coronary Artery Disease: Diagnosis and Management
Cassar, A., Holmes, D. R., Rihal, C. S., & Gersh, B. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0391 · Cited by 324
Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve
Park, S.-J., Kang, S.-J., Ahn, J.-M., Shim, E. B., Kim, Y.-T., Yun, S.-C., Song, H., Lee, J.-Y., Kim, W.-J., Park, D.-W., et al. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.07.007 · Cited by 329
“Instead, coronary angiography is still used as a cornerstone for decision making regarding revascularization treatment for patients without any evidence of objective ischemia (1,2).”
MethodOwens, D. K., Qaseem, A., Chou, R., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-3-201102010-00007 · Cited by 329
8. Cardiovascular Disease and Risk Management
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s011 · Cited by 329
Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses
Toth, G., Hamilos, M., Pyxaras, S., Mangiacapra, F., Nelis, O., De Vroey, F., Di Serafino, L., Muller, O., Van Mieghem, C., Wyffels, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu094 · Cited by 329
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., et al. (2010) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22537 · Cited by 330
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m09_01 · Cited by 328
George, R. T., Arbab-Zadeh, A., Miller, J. M., Kitagawa, K., Chang, H.-J., Bluemke, D. A., Becker, L., Yousuf, O., Texter, J., Lardo, A. C., et al. (2009) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.108.813766 · Cited by 324
Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
Cutler, D., Skinner, J. S., Stern, A. D., & Wennberg, D. (2019) · American Economic Journal: Economic Policy · doi:10.1257/pol.20150421 · Cited by 313
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics
Timmis, A., Aboyans, V., Vardas, P., Townsend, N., Torbica, A., Kavousi, M., Boriani, G., Huculeci, R., Kazakiewicz, D., Scherr, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae466 · Cited by 314
Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis
Kelshiker, M. A., Seligman, H., Howard, J. P., Rahman, H., Foley, M., Nowbar, A. N., Rajkumar, C. A., Shun-Shin, M. J., Ahmad, Y., Sen, S., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab775 · Cited by 311
Lentine, K. L., Costa, S. P., Weir, M. R., Robb, J. F., Fleisher, L. A., Kasiske, B. L., Carithers, R. L., Ragosta, M., Bolton, K., Auerbach, A. D., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823eb07a · Cited by 314
Hueb, W., Lopes, N., Gersh, B. J., Soares, P. R., Ribeiro, E. E., Pereira, A. C., Favarato, D., Rocha, A. S. C., Hueb, A. C., & Ramires, J. A. F. (2010) · Circulation · doi:10.1161/circulationaha.109.911669 · Cited by 317
Erne, P., Schoenenberger, A. W., Burckhardt, D., Zuber, M., Kiowski, W., Buser, P. T., Dubach, P., Resink, T. J., & Pfisterer, M. (2007) · JAMA · doi:10.1001/jama.297.18.1985 · Cited by 311
“Thus, these findings reflect the standard of clinical practice in patients with significant post-MI silent ischemia, patients who are different from most who were enrolled in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.(23) Recently, the Open Artery Trial (OAT) repo…”
BackgroundVlaar, P. J., Mahmoud, K. D., Holmes, D. R., van Valkenhoef, G., Hillege, H. L., van der Horst, I. C. C., Zijlstra, F., & de Smet, B. J. G. L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.046 · Cited by 305
Coronary Artery Disease and Transcatheter Aortic Valve Replacement
Faroux, L., Guimaraes, L., Wintzer-Wehekind, J., Junquera, L., Ferreira-Neto, A. N., del Val, D., Muntané-Carol, G., Mohammadi, S., Paradis, J.-M., & Rodés-Cabau, J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.06.012 · Cited by 304
“Indeed, randomized trials failed to demonstrate a clear beneficial effect of PCI in stable CAD patients (33,34), and current guidelines state that performing PCI in the presence of a coronary artery stenosis >70% in proximal coronary segments during the pre-TAVR work-up lacks scientific evidence (35,36).”
BackgroundArnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Functional Measurement of Coronary Stenosis
Pijls, N. H. J., & Sels, J.-W. E. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.077 · Cited by 296
Kussmaul, W. G. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00015 · Cited by 296
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
Sedlis, S. P., Hartigan, P. M., Teo, K. K., Maron, D. J., Spertus, J. A., Mancini, G. B. J., Kostuk, W., Chaitman, B. R., Berman, D., Lorin, J. D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505532 · Cited by 294
“525/2214 (24) 545/2241 (24) 449/2036 (22) 241/913 (26) 419/1888 (22) 141/704 (20) 290/1482 (20) 57/338 (17) 71/452 (16) 163/990 (16) 55/1076 (5)”
Self-citationImpact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis
Mortensen, M. B., Dzaye, O., Steffensen, F. H., Bøtker, H. E., Jensen, J. M., Rønnow Sand, N. P., Kragholm, K. H., Sørensen, H. T., Leipsic, J., Mæng, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.021 · Cited by 289
Arbab-Zadeh, A., Nakano, M., Virmani, R., & Fuster, V. (2012) · Circulation · doi:10.1161/circulationaha.111.047431 · Cited by 284
Tarkin, J. M., Dweck, M. R., Evans, N. R., Takx, R. A. P., Brown, A. J., Tawakol, A., Fayad, Z. A., & Rudd, J. H. F. (2016) · Circulation Research · doi:10.1161/circresaha.115.306247 · Cited by 284
Randomized Clinical Trials and Observational Studies
Hannan, E. L. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.01.008 · Cited by 283
Current Concepts of Integrated Coronary Physiology in the Catheterization Laboratory
Kern, M. J., & Samady, H. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.062 · Cited by 283
Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy
Kini, A. S., Baber, U., Kovacic, J. C., Limaye, A., Ali, Z. A., Sweeny, J., Maehara, A., Mehran, R., Dangas, G., Mintz, G. S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.058 · Cited by 279
“Figure 1 Flow Diagram The diagram depicts study patient enrollment, randomization, and coronary imaging in the YELLOW trial, among patients with stable coronary artery disease Abbreviations and Acronyms ANCOVA = analysis of covariance CAD = coronary artery disease FFR = fractional flow reserve IVUS = intravascular ult…”
InfluentialStergiopoulos, K., Boden, W. E., Hartigan, P., Möbius-Winkler, S., Hambrecht, R., Hueb, W., Hardison, R. M., Abbott, J. D., & Brown, D. L. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12855 · Cited by 278
Self-citation2007 WRITING COMMITTEE MEMBERS, Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828478ac · Cited by 272
Senthong, V., Wang, Z., Li, X. S., Fan, Y., Wu, Y., Wilson Tang, W. H., & Hazen, S. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002816 · Cited by 270
“revascularization plus optimal medical treatment (OMT) versus OMT alone.(18) We sought to examine the relationship between fasting plasma TMAO levels and long-term clinical prognosis in patients with stable CAD who had significant coronary artery stenosis detected on elective coronary angiography and were managed with…”
Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes
Everett, B. M., Brooks, M. M., Vlachos, H. E. A., Chaitman, B. R., Frye, R. L., & Bhatt, D. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415921 · Cited by 268
Self-citationObstructive Coronary Atherosclerosis and Ischemic Heart Disease: An Elusive Link!
Marzilli, M., Merz, C. N. B., Boden, W. E., Bonow, R. O., Capozza, P. G., Chilian, W. M., DeMaria, A. N., Guarini, G., Huqi, A., Morrone, D., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.082 · Cited by 265
Self-citationModelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
Björck, L., Rosengren, A., Bennett, K., Lappas, G., & Capewell, S. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn554 · Cited by 264
Chaitman, B. R., Hardison, R. M., Adler, D., Gebhart, S., Grogan, M., Ocampo, S., Sopko, G., Ramires, J. A., Schneider, D., Frye, R. L., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.913111 · Cited by 263
Self-citationMaron, D. J., Hochman, J. S., O’Brien, S. M., Reynolds, H. R., Boden, W. E., Stone, G. W., Bangalore, S., Spertus, J. A., Mark, D. B., Alexander, K. P., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.04.011 · Cited by 262
“Trial leadership sought DSMB approval to include non-imaging exercise testing for the following reasons: (1) non-imaging exercise testing is the most widely used modality worldwide; (2) this modality is recommended as preferred by the American College of Cardiology/American Heart Association guidelines for patients wi…”
InfluentialSelf-citationCardiovascular risk assessment in patients with diabetes
Bertoluci, M. C., & Rocha, V. Z. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0225-1 · Cited by 255
“In these presumed cases, patients should benefit of intensive prevention similarly as invasive revascularization treatment [95, 96].”
BackgroundLong-Term Follow-Up of Elective Chronic Total Coronary Occlusion Angioplasty
George, S., Cockburn, J., Clayton, T. C., Ludman, P., Cotton, J., Spratt, J., Redwood, S., de Belder, M., de Belder, A., Hill, J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.040 · Cited by 255
Screening for coronary artery disease in patients with diabetes
Bax, J. J., Young, L. H., Frye, R. L., Bonow, R. O., Steinberg, H. O., & Barrett, E. J. (2007) · Diabetes Care · doi:10.2337/dc07-9927 · Cited by 251
Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B., Lamm, D., O'Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 252
Nallamothu, B. K., Hayward, R. A., & Bates, E. R. (2008) · Circulation · doi:10.1161/circulationaha.107.703579 · Cited by 250
“41 They are designed to overcome many of the potential limitations of RCTs by including (1) use of active controls and clinically relevant comparisons, (2) broad study populations, (3) enrollment from diverse clinical environments, (4) evaluations of strategies of treatment rather than single drugs or devices, and (5)…”
BackgroundSelf-citationFearon, W. F., Nishi, T., De Bruyne, B., Boothroyd, D. B., Barbato, E., Tonino, P., Jüni, P., Pijls, N. H. J., & Hlatky, M. A. (2018) · Circulation · doi:10.1161/circulationaha.117.031907 · Cited by 251
Rao, S. V., Hess, C. N., Barham, B., Aberle, L. H., Anstrom, K. J., Patel, T. B., Jorgensen, J. P., Mazzaferri, E. L., Jolly, S. S., Jacobs, A., et al. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.04.007 · Cited by 249
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.015 · Cited by 248
Stone, P. H., Libby, P., & Boden, W. E. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2022.3926 · Cited by 242
Self-citationDrug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction
Mauri, L., Silbaugh, T. S., Garg, P., Wolf, R. E., Zelevinsky, K., Lovett, A., Varma, M. R., Zhou, Z., & Normand, S.-L. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801485 · Cited by 245
Trikalinos, T. A., Alsheikh-Ali, A. A., Tatsioni, A., Nallamothu, B. K., & Kent, D. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60319-6 · Cited by 243
Mieres, J. H., Gulati, M., Bairey Merz, N., Berman, D. S., Gerber, T. C., Hayes, S. N., Kramer, C. M., Min, J. K., Newby, L. K., Nixon, J. V. (., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000061 · Cited by 244
Self-citation2020 Clinical practice guidelines for Stable coronary artery disease
Russian Society of Cardiology (RSC) (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4076 · Cited by 242
Alkhouli, M., Alqahtani, F., Kalra, A., Gafoor, S., Alhajji, M., Alreshidan, M., Holmes, D. R., & Lerman, A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.21326 · Cited by 240
Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database
Feng, M., McSparron, J. I., Kien, D. T., Stone, D. J., Roberts, D. H., Schwartzstein, R. M., Vieillard-Baron, A., & Celi, L. A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5208-7 · Cited by 239
Desai, N. R., Bradley, S. M., Parzynski, C. S., Nallamothu, B. K., Chan, P. S., Spertus, J. A., Patel, M. R., Ader, J., Soufer, A., Krumholz, H. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.13764 · Cited by 237
Self-citationFihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.012 · Cited by 237
Self-citationA Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
Rajkumar, C. A., Foley, M. J., Ahmed-Jushuf, F., Nowbar, A. N., Simader, F. A., Davies, J. R., O’Kane, P. D., Haworth, P., Routledge, H., Kotecha, T., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2310610 · Cited by 233
Wijns, W., Shite, J., Jones, M. R., Lee, S. W.-L., Price, M. J., Fabbiocchi, F., Barbato, E., Akasaka, T., Bezerra, H., & Holmes, D. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv367 · Cited by 236
Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease
Heusch, G. (2024) · Med · doi:10.1016/j.medj.2023.12.007 · Cited by 228
“…we are back to square one, and the jury is still out on whether PCI or conservative therapy is preferable, as PCI—except for left main stem coronary stenosis, which threatens the perfusion of the entire left ventricle—does not improve prognosis 3,4 and does not relieve symptoms in 20%– 40% cases.”
8. Cardiovascular Disease and Risk Management
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s011 · Cited by 233
Lin, G. A. (2008) · JAMA · doi:10.1001/jama.300.15.1765 · Cited by 231
(2015) · Journal of Nuclear Cardiology · doi:10.1007/s12350-014-0025-z · Cited by 230
Meta‐research: The art of getting it wrong
Ioannidis, J. P. A. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.19 · Cited by 227
“Our meta-analysis in 2005 (Ioannidis and Katritsis, 2005) found no benefit from invasive management, and a large randomized trial published 2 years later also found no benefit (Boden et al., 2007).”
Calcification in atherosclerosis
Alexopoulos, N., & Raggi, P. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.165 · Cited by 226
“Furthermore, studies have shown that the pursuit of a stenosis via percutaneous coronary intervention provides similar or inferior results to intensive medical therapy”
Result10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s010 · Cited by 225
Tomasello, S. D., Boukhris, M., Giubilato, S., Marzà, F., Garbo, R., Contegiacomo, G., Marzocchi, A., Niccoli, G., Gagnor, A., Varbella, F., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv450 · Cited by 223
9. Cardiovascular Disease and Risk Management
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s012 · Cited by 223
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., de las Fuentes, L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.013 · Cited by 209
Fleg, J. L., Forman, D. E., Berra, K., Bittner, V., Blumenthal, J. A., Chen, M. A., Cheng, S., Kitzman, D. W., Maurer, M. S., Rich, M. W., et al. (2013) · Circulation · doi:10.1161/01.cir.0000436752.99896.22 · Cited by 219
Bashore, T. M., Balter, S., Barac, A., Byrne, J. G., Cavendish, J. J., Chambers, C. E., Hermiller, J. B., Kinlay, S., Landzberg, J. S., Laskey, W. K., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.010 · Cited by 220
Vanhees, L., Rauch, B., Piepoli, M., van Buuren, F., Takken, T., Börjesson, M., Bjarnason-Wehrens, B., Doherty, P., Dugmore, D., Halle, M., et al. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312437063 · Cited by 215
Pursnani, S., Korley, F., Gopaul, R., Kanade, P., Chandra, N., Shaw, R. E., & Bangalore, S. (2012) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.112.970954 · Cited by 214
Metadata
- Authors
- Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B. J., & Weintraub, W. S.
- Affiliations
- VA Western New York Healthcare System (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-12
- Volume
- 356
- Issue
- 15
- Pages
- 1503-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160414137
- Cited by
- 4,699
- References
- 49
- Citations by year
- 2026: 111 · 2025: 142 · 2024: 150 · 2023: 166 · 2022: 197 · 2021: 255 · 2020: 282 · 2019: 202 · 2018: 227 · 2017: 211 · 2016: 276 · 2015: 263 · 2014: 295 · 2013: 309 · 2012: 322
- FWCI
- 315.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- optimal medical therapy, percutaneous coronary intervention, stable coronary artery disease, myocardial ischemia, cardiovascular events, myocardial infarction, mortality, lifestyle intervention, coronary artery disease
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angina Pectoris, Angiotensin-Converting Enzyme Inhibitors, Anticholesteremic Agents, Antihypertensive Agents, Combined Modality Therapy, Coronary Disease, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Risk Factors, Angioplasty, Balloon, Coronary, Proportional Hazards Models, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.